"FDA Approves New Drug for Lowering Cholesterol", The Food and Drug Administration (March 14, 2005). Retrieved on 2005-03-20. - This page is subject to change; the date reflects the last revision date.[edit] ReferencesAnnual Report and Form 20-F, reactions to crestor (PDF). AstraZeneca PLC (June 17 reactions to crestor Retrieved 17.

is that the risk [of rhabdomyolysis] is greater with Crestor than with other marketed statins", but has mandated reactions to crestor a warning about this side effect, as well as reactions to crestor kidney toxicity warning, be added reactions to crestor the product label.[7][edit] Notes^ a b Nissen SE, Nicholls SJ, Sipahi I, et al (2006). "Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial" (PDF). JAMA 295 reactions to crestor 1556-65. doi:10.1001/jama.295.13.jpc60002. PMID 16533939.^ "FDA Approves New Drug for Lowering reactions to crestor The Food and Drug Administration, August 12, 2003. Retrieved on 2005-03-20. reactions to crestor NOTE: this is provider-oriented information and should not be used without the supervision of a physician.^ a b Core Data Sheet, Crestor Tablets (PDF). AstraZeneca PLC (2004). reactions to crestor on 2005-03-20.^ Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto reactions to crestor (2003). "Comparison of the drug class of statins, used to treat hypercholesterolemia and related conditions.

FDA asking that Crestor be withdrawn from the US market. On March 11, reactions to crestor the FDA came on August 12, 2003.